Role of Hepatitis B Virus Infection in the Prognosis After Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis: A Western Dual-Center Experience | Gastroenterology | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
El-Serag  HBDavila  JAPetersen  NJ McGlynn  KA The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.  Ann Intern Med 2003;139 (10) 817- 823PubMedGoogle ScholarCrossref
2.
Belghiti  JPanis  YFarges  OBenhamou  JPFekete  F Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.  Ann Surg 1991;214 (2) 114- 117PubMedGoogle ScholarCrossref
3.
Poon  RTPFan  STLo  CMLiu  CLWong  J Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation.  Ann Surg 2002;235 (3) 373- 382PubMedGoogle ScholarCrossref
4.
Yamanaka  NOkamoto  EToyosaka  A  et al.  Prognostic factors after hepatectomy for hepatocellular carcinoma: a univariate and multivariate analysis.  Cancer 1990;65 (5) 1104- 1110PubMedGoogle ScholarCrossref
5.
Chen  MFHwang  TLJeng  LBWang  CSJan  YYChen  SC Postoperative recurrence of hepatocellular carcinoma: two hundred five consecutive patients who underwent hepatic resection in 15 years.  Arch Surg 1994;129 (7) 738- 742PubMedGoogle ScholarCrossref
6.
Nagasue  NUchida  MMakino  Y  et al.  Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma.  Gastroenterology 1993;105 (2) 488- 494PubMedGoogle ScholarCrossref
7.
Poon  RTFan  STLo  CMLiu  CLNg  IOWong  J Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.  J Clin Oncol 2000;18 (5) 1094- 1101PubMedGoogle Scholar
8.
Poon  RTFan  STLo  CM  et al.  Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years.  Ann Surg 2001;234 (1) 63- 70PubMedGoogle ScholarCrossref
9.
Wayne  JDLauwers  GYIkai  I  et al.  Preoperative predictors of survival after resection of small hepatocellular carcinomas.  Ann Surg 2002;235 (5) 722- 731PubMedGoogle ScholarCrossref
10.
Ercolani  GGrazi  GLRavaioli  M  et al.  Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.  Ann Surg 2003;237 (4) 536- 543PubMedGoogle Scholar
11.
Capussotti  LMuratore  AAmisano  MPolastri  RBouzari  HMassucco  P Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival: a European single center experience.  Eur J Surg Oncol 2005;31 (9) 986- 993PubMedGoogle ScholarCrossref
12.
Chen  JHChau  GYLui  WY  et al.  Surgical results in patients with hepatitis B–related hepatocellular carcinoma and positive hepatitis B early antigen.  World J Surg 2000;24 (3) 383- 388PubMedGoogle ScholarCrossref
13.
Sun  HCZhang  WQin  LX  et al.  Positive serum hepatitis e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.  J Hepatol 2007;47 (5) 684- 690PubMedGoogle ScholarCrossref
14.
Roayaie  SHaim  MBEmre  S  et al.  Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.  Ann Surg Oncol 2000;7 (10) 764- 770PubMedGoogle ScholarCrossref
15.
Sasaki  YYamada  TTanaka  H  et al.  Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma.  Ann Surg 2006;244 (5) 771- 780PubMedGoogle ScholarCrossref
16.
Kubo  SHirohashi  KYamazaki  O  et al.  Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B.  World J Surg 2002;26 (5) 555- 560PubMedGoogle ScholarCrossref
17.
Grazi  GLErcolani  GPierangeli  F  et al.  Improved results of liver resections for hepatocellular carcinoma on cirrhosis give the procedure added value.  Ann Surg 2001;234 (1) 71- 78PubMedGoogle ScholarCrossref
18.
Committee of the International Hepato-Pancreato-Biliary Association, IHPBA Brisbane Terminology of Liver Anatomy and Resections. Vol 2 Abingdon, England Taylor & Francis2000;333- 339
19.
Mazzaferro  VRegalia  EDoci  R  et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.  N Engl J Med 1996;334 (11) 693- 699PubMedGoogle ScholarCrossref
20.
Child  CG  IITurcotte  JG Surgery and portal hypertension. Child  CG  III The Liver and Portal Hypertension Philadelphia, PA WB Saunders Co1964;50- 58Google Scholar
21.
Pugh  RNMurray-Lyon  IMDawson  JLPietroni  MCWilliams  R Transection of the oesophagus for bleeding oesophageal varices.  Br J Surg 1973;60 (8) 646- 649PubMedGoogle ScholarCrossref
22.
Freeman  RB  JrWiesner  RHHarper  A  et al. UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees, The new liver allocation system: moving toward evidence-based transplantation policy.  Liver Transpl 2002;8 (9) 851- 858PubMedGoogle ScholarCrossref
23.
Edmondson  HASteiner  PE Primary carcinoma of the liver: a study of 100 cases among 48 900 necropsies.  Cancer 1954;7 (3) 462- 503PubMedGoogle ScholarCrossref
24.
Imamura  HMatsuyama  YTanaka  E  et al.  Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.  J Hepatol 2003;38 (2) 200- 207PubMedGoogle ScholarCrossref
25.
Pollicino  TSquadrito  GCerenzia  G  et al.  Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.  Gastroenterology 2004;126 (1) 102- 110PubMedGoogle ScholarCrossref
26.
Squadrito  GPollicino  TCacciola  I  et al.  Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.  Cancer 2006;106 (6) 1326- 1330PubMedGoogle ScholarCrossref
27.
Ikeda  KMarusawa  HOsaki  Y  et al.  Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.  Ann Intern Med 2007;146 (9) 649- 656PubMedGoogle ScholarCrossref
28.
Liaw  YFSung  JJYChow  WC  et al. Cirrhosis Asian Lamivudine Multicentre Study Group, Lamivudine for patients with chronic hepatitis B and advanced liver disease.  N Engl J Med 2004;351 (15) 1521- 1531PubMedGoogle ScholarCrossref
29.
Lau  GKPiratvisuth  TLuo  KX  et al. Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group, Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.  N Engl J Med 2005;352 (26) 2682- 2695PubMedGoogle ScholarCrossref
30.
Lin  SMYu  MLLee  CM  et al.  Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.  J Hepatol 2007;46 (1) 45- 52PubMedGoogle ScholarCrossref
31.
Mazzaferro  VRomito  RSchiavo  M  et al. HCC Italian Task Force, Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.  Hepatology 2006;44 (6) 1543- 1554PubMedGoogle ScholarCrossref
32.
Poon  RTFan  STLo  CMLiu  CLWong  J Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival.  Ann Surg 2007;245 (1) 51- 58PubMedGoogle ScholarCrossref
Original Article
October 19, 2009

Role of Hepatitis B Virus Infection in the Prognosis After Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis: A Western Dual-Center Experience

Author Affiliations

Author Affiliations: Liver and Multiorgan Transplant Unit, Department of Surgery and Transplantation (Drs Cescon, Cucchetti, Grazi, Ercolani, Ravaioli, Zanello, and Pinna), and Department of Digestive Diseases and Internal Medicine (Dr Andreone), University of Bologna, Bologna, Italy; and Unit of Surgical Oncology, Institute for Cancer Research and Treatment, Candiolo, Turin, Italy (Drs Ferrero, Vigan[[ograve]], and Capussotti).

Arch Surg. 2009;144(10):906-913. doi:10.1001/archsurg.2009.99
Abstract

Hypothesis  The role of hepatitis B virus (HBV) infection in determining the prognosis after hepatectomy for hepatocellular carcinoma (HCC) in patients with cirrhosis is controversial.

Design  Retrospective study based on multicenter prospectively updated databases.

Setting  Two tertiary referral centers specializing in hepatobiliary surgery.

Patients  Two hundred four consecutive patients with cirrhosis undergoing hepatectomy for single nodules of HCC of 5 cm or smaller from January 1, 1997, through September 30, 2006.

Interventions  Patients were divided into the following groups according to their preoperative viral status: HBV positive and hepatitis C virus (HCV) negative (group 1); HBV negative and HCV positive (group 2); HBV negative and HCV negative (group 3); and HBV positive and HCV positive (group 4).

Main Outcome Measures  A multivariate analysis was performed to determine factors associated with recurrence-free survival (RFS) among demographic, clinical, pathological, and surgical variables.

Results  The 2 centers had comparable RFS and early and late recurrence rates. Five-year RFS was significantly higher in groups 2 and 3 compared with group 1 (38%, 34%, and 9%, respectively; P = .007 and P = .05). Factors independently associated with RFS were HBV infection (P = .009; odds ratio, 1.79; 95% confidence interval, 1.15-2.78) and poor tumor differentiation (P < .001; odds ratio, 2.01; 95% confidence interval, 1.36-2.96). The concomitance of 0, 1, or 2 risk factors led to 5-year RFS rates of 49%, 20%, and 8%, respectively (P < .001).

Conclusions  Infection with HBV is a strong predictive factor for lower RFS after hepatectomy for a single nodule of HCC of 5 cm or smaller in patients with cirrhosis, providing a further basis for adjuvant antiviral treatment. Patients who are seropositive for HBV with poorly differentiated HCC should also be considered to be at a high risk of recurrence and possibly included in a policy of salvage liver transplantation.

×